Product NDC: | 59762-5010 |
Proprietary Name: | clindamycin hydrochloride |
Non Proprietary Name: | CLINDAMYCIN HYDROCHLORIDE |
Active Ingredient(s): | 300 mg/1 & nbsp; CLINDAMYCIN HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59762-5010 |
Labeler Name: | Greenstone LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050162 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19700522 |
Package NDC: | 59762-5010-1 |
Package Description: | 16 CAPSULE in 1 BOTTLE (59762-5010-1) |
NDC Code | 59762-5010-1 |
Proprietary Name | clindamycin hydrochloride |
Package Description | 16 CAPSULE in 1 BOTTLE (59762-5010-1) |
Product NDC | 59762-5010 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLINDAMYCIN HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19700522 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Greenstone LLC |
Substance Name | CLINDAMYCIN HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |